United States · Regional markets · Decrypt

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Published by Decrypt · United States 2 h ago

The ChatGPT maker is folding Orchestra’s drug-program agents into Rosalind, its life sciences suite, betting AI can shave time off the decade-plus it takes to bring a medicine to…

Read the full article on Decrypt Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (decrypt.co)

Also worth reading

Business Insider

SpaceX says its capex could double this quarter as AI spending grows

Washington Post Business

OpenAI Buys Orchestra Bio to Put AI Agents in Charge of Drug Development Grunt Work

Share

Also worth reading

SpaceX says its capex could double this quarter as AI spending grows

Riots leave France divided and shadowed by debt as Macron enters his final run